Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2021 Jul 1

PMID 34194298

Citations 4

Authors

Xiaolin Zhu

Yu Zhang

Xin Yang

Chunyan Hao

Hubin Duan

Affiliations

Soon will be listed here.

Abstract

The pathogenesis of neurodegenerative diseases (NDDs) is complex and diverse. Over the decades, our understanding of NDD has been limited to pathological features. However, recent advances in gene sequencing have facilitated elucidation of NDD at a deeper level. Gene editing techniques have uncovered new genetic links to phenotypes, promoted the development of novel treatment strategies and equipped researchers with further means to construct effective cell and animal models. The current review describes the history of evolution of gene editing tools, with the aim of improving overall understanding of this technology, and focuses on the four most common NDD disorders to demonstrate the potential future applications and research directions of gene editing.

Citing Articles

Viruses and neurodegeneration: a growing concern.

Shouman S, Hesham N, Salem T J Transl Med. 2025; 23(1):46.

PMID: 39800721 PMC: 11727702. DOI: 10.1186/s12967-024-06025-6.

Brain Nucleic Acid Delivery and Genome Editing via Focused Ultrasound-Mediated Blood-Brain Barrier Opening and Long-Circulating Nanoparticles.

Kwak G, Grewal A, Slika H, Mess G, Li H, Kwatra M ACS Nano. 2024; 18(35):24139-24153.

PMID: 39172436 PMC: 11792178. DOI: 10.1021/acsnano.4c05270.

Emerging Perspectives on Prime Editor Delivery to the Brain.

BenDavid E, Ramezanian S, Lu Y, Rousseau J, Schroeder A, Lavertu M Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931430 PMC: 11206523. DOI: 10.3390/ph17060763.

The Role of Oxidative Stress in Trisomy 21 Phenotype.

Buczynska A, Sidorkiewicz I, Kretowski A, Zbucka-Kretowska M Cell Mol Neurobiol. 2023; 43(8):3943-3963.

PMID: 37819608 PMC: 10661812. DOI: 10.1007/s10571-023-01417-6.

Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection.

Voronin M, Abramova E, Verbovaya E, Vakhitova Y, Seredenin S Int J Mol Sci. 2023; 24(1).

PMID: 36614266 PMC: 9820882. DOI: 10.3390/ijms24010823.

References

Chen V, Moncalvo M, Tringali D, Tagliafierro L, Shriskanda A, Ilich E . The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson's disease SNCA mutations. Hum Mol Genet. 2020; 29(18):3107-3121. PMC: 7645704. DOI: 10.1093/hmg/ddaa183. View

Kowalczykowski S . An Overview of the Molecular Mechanisms of Recombinational DNA Repair. Cold Spring Harb Perspect Biol. 2015; 7(11). PMC: 4632670. DOI: 10.1101/cshperspect.a016410. View

Lieber M . The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010; 79:181-211. PMC: 3079308. DOI: 10.1146/annurev.biochem.052308.093131. View

Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S . Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009; 326(5959):1509-12. DOI: 10.1126/science.1178811. View

Mehta A, Haber J . Sources of DNA double-strand breaks and models of recombinational DNA repair. Cold Spring Harb Perspect Biol. 2014; 6(9):a016428. PMC: 4142968. DOI: 10.1101/cshperspect.a016428. View

Carroll D . Genome engineering with zinc-finger nucleases. Genetics. 2011; 188(4):773-82. PMC: 3176093. DOI: 10.1534/genetics.111.131433. View

Renton A, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs J . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72(2):257-68. PMC: 3200438. DOI: 10.1016/j.neuron.2011.09.010. View

Inoue N, Ogura S, Kasai A, Nakazawa T, Ikeda K, Higashi S . Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism. EMBO Rep. 2018; 19(3). PMC: 5836091. DOI: 10.15252/embr.201744860. View

Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C . Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45(12):1452-8. PMC: 3896259. DOI: 10.1038/ng.2802. View

10.

Kim B, Ryu J, Jeong Y, Kim J, Martin L . Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis. Front Cell Neurosci. 2020; 14:604171. PMC: 7710664. DOI: 10.3389/fncel.2020.604171. View

11.

Barbuti P, Antony P, Santos B, Massart F, Cruciani G, Dording C . Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P. Cells. 2020; 9(9). PMC: 7564375. DOI: 10.3390/cells9092065. View

12.

Goate A, Chartier-Harlin M, Mullan M, Brown J, Crawford F, Fidani L . Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991; 349(6311):704-6. DOI: 10.1038/349704a0. View

13.

San Filippo J, Sung P, Klein H . Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008; 77:229-57. DOI: 10.1146/annurev.biochem.77.061306.125255. View

14.

Liu Q, Segal D, Ghiara J, Barbas 3rd C . Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc Natl Acad Sci U S A. 1997; 94(11):5525-30. PMC: 20811. DOI: 10.1073/pnas.94.11.5525. View

15.

Symington L, Gautier J . Double-strand break end resection and repair pathway choice. Annu Rev Genet. 2011; 45:247-71. DOI: 10.1146/annurev-genet-110410-132435. View

16.

Ahfeldt T, Ordureau A, Bell C, Sarrafha L, Sun C, Piccinotti S . Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons. Stem Cell Reports. 2020; 14(1):75-90. PMC: 6962705. DOI: 10.1016/j.stemcr.2019.12.005. View

17.

Muller K, Brenner D, Weydt P, Meyer T, Grehl T, Petri S . Comprehensive analysis of the mutation spectrum in 301 German ALS families. J Neurol Neurosurg Psychiatry. 2018; 89(8):817-827. DOI: 10.1136/jnnp-2017-317611. View

18.

Porter T, Burnham S, Milicic L, Savage G, Maruff P, Lim Y . Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease. Neurobiol Aging. 2019; 76:162-165. DOI: 10.1016/j.neurobiolaging.2018.12.014. View

19.

Malankhanova T, Suldina L, Grigoreva E, Medvedev S, Minina J, Morozova K . A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities. J Pers Med. 2020; 10(4). PMC: 7712151. DOI: 10.3390/jpm10040215. View

20.

Miller J, Tan S, Qiao G, Barlow K, Wang J, Xia D . A TALE nuclease architecture for efficient genome editing. Nat Biotechnol. 2010; 29(2):143-8. DOI: 10.1038/nbt.1755. View